Maianskiĭ D N, Tsyrendorzhiev D D, Makarova O P, Norris A A
Eksp Klin Farmakol. 1995 May-Jun;58(3):34-7.
Nedocromil sodium in concentrations of 10(-3) to 10(-9) M dose-dependently inhibits a zymosan (2 mg/ml)-induced chemiluminescence response (CLR) of whole blood leukocytes and, to a lesser extent, phorbol myrystate acetate (PMA)-induced CLR. The count of diformazan-positive granulocytes in the zymosan-induced nitroblue tetrazolium test slightly reduced in the presence of 10(5) nedocromil sodium. PMA in a dose of 10(-9) M did not induce CLR, but brought about leukocyte priming, thus sensitizing them to secondary triggering by suboptimal zymosan concentrations (0.5 mg/ml). A subsequent stimulation of leukocytes with PMA + zymosan demonstrated that nedocromil sodium (10(-7) M) inhibited mainly priming PMA rather than the zymosan-triggering step of leukocyte activation.
浓度为10⁻³至10⁻⁹M的奈多罗米钠剂量依赖性地抑制酵母聚糖(2mg/ml)诱导的全血白细胞化学发光反应(CLR),并在较小程度上抑制佛波酯(PMA)诱导的CLR。在10⁻⁵奈多罗米钠存在的情况下,酵母聚糖诱导的硝基蓝四唑试验中二甲瓒阳性粒细胞计数略有减少。10⁻⁹M剂量的PMA不诱导CLR,但可引起白细胞致敏,从而使它们对次优酵母聚糖浓度(0.5mg/ml)的二次触发敏感。随后用PMA + 酵母聚糖刺激白细胞表明,奈多罗米钠(10⁻⁷M)主要抑制致敏性PMA,而不是白细胞激活的酵母聚糖触发步骤。